These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 11928574

  • 21. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P, Nguyen H, Barbier A, Baron R.
    J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor.
    van Beek E, Löwik C, Karperien M, Papapoulos S.
    Bone; 2006 Feb; 38(2):167-71. PubMed ID: 16165408
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
    Coxon FP, Helfrich MH, Van't Hof R, Sebti S, Ralston SH, Hamilton A, Rogers MJ.
    J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
    [Abstract] [Full Text] [Related]

  • 28. Zoledronic acid-induced IPP/ApppI production in vivo.
    Mönkkönen H, Ottewell PD, Kuokkanen J, Mönkkönen J, Auriola S, Holen I.
    Life Sci; 2007 Sep 08; 81(13):1066-70. PubMed ID: 17850825
    [Abstract] [Full Text] [Related]

  • 29. [Mechanisms of action in bisphosphonates].
    Hoshino H, Yamazaki K.
    Clin Calcium; 2005 Jul 08; 15(7):88-92. PubMed ID: 15995302
    [Abstract] [Full Text] [Related]

  • 30. [The role of mevalonate pathway in osteogenic cells].
    Ishimi Y.
    Nihon Rinsho; 2004 Feb 08; 62 Suppl 2():779-82. PubMed ID: 15035226
    [No Abstract] [Full Text] [Related]

  • 31. Review of the Mechanism of Action and Use of Bisphosphonates in Horses.
    Yocom A, Contino E, Kawcak C.
    J Equine Vet Sci; 2023 Aug 08; 127():104503. PubMed ID: 37120118
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Bisphosphonates: pharmacology, mechanisms of action and clinical uses.
    Russell RG, Croucher PI, Rogers MJ.
    Osteoporos Int; 1999 Aug 08; 9 Suppl 2():S66-80. PubMed ID: 10525729
    [No Abstract] [Full Text] [Related]

  • 34. The antitumor potential of bisphosphonates.
    Clézardin P.
    Semin Oncol; 2002 Dec 08; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells.
    Das S, Edwards PA, Crockett JC, Rogers MJ.
    Biochim Biophys Acta; 2014 Apr 04; 1841(4):569-73. PubMed ID: 24369118
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Biochemical and molecular mechanisms of action of bisphosphonates.
    Rogers MJ, Crockett JC, Coxon FP, Mönkkönen J.
    Bone; 2011 Jul 04; 49(1):34-41. PubMed ID: 21111853
    [Abstract] [Full Text] [Related]

  • 39. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM, Senaratne SG, Clarke IA, Kirby RS, Colston KW.
    J Urol; 2003 Jul 04; 170(1):246-52. PubMed ID: 12796698
    [Abstract] [Full Text] [Related]

  • 40. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
    Ling Y, Sahota G, Odeh S, Chan JM, Araujo FG, Moreno SN, Oldfield E.
    J Med Chem; 2005 May 05; 48(9):3130-40. PubMed ID: 15857119
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.